Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma
- PMID: 1679237
- PMCID: PMC52396
- DOI: 10.1073/pnas.88.17.7825
Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma
Abstract
We detected a germ-line mutation of the p53 gene in a patient with a malignant ependymoma of the posterior fossa. This mutation, which was found at codon 242, resulted in an amino acid substitution in a highly conserved site of exon 7 of the p53 gene; the same mutation was found in both the germ-line and the tumor tissue. This is the most common region of previously described somatic p53 mutations in tumor specimens and of the germ-line p53 mutations in patients with the Li-Fraumeni cancer syndrome. Evaluation of the patient's family revealed several direct maternal and paternal relatives who had died at a young age from different types of cancer. The association of a germ-line p53 mutation with an intracranial malignancy and a strong family history of cancer suggests that p53 gene mutations predispose a person to malignancy and, like retinoblastoma mutations, may be inherited.
Similar articles
-
Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma.J Natl Cancer Inst. 1992 May 6;84(9):703-7. doi: 10.1093/jnci/84.9.703. J Natl Cancer Inst. 1992. PMID: 1569604
-
Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family.Pediatr Blood Cancer. 2008 Apr;50(4):914-6. doi: 10.1002/pbc.21247. Pediatr Blood Cancer. 2008. PMID: 17554785
-
Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6413-7. doi: 10.1073/pnas.89.14.6413. Proc Natl Acad Sci U S A. 1992. PMID: 1631137 Free PMC article.
-
Cancer risks from germ line tumor suppressor gene mutations.Princess Takamatsu Symp. 1991;22:61-70. Princess Takamatsu Symp. 1991. PMID: 1844252 Review.
-
Rare occurrence of inactivating p53 gene mutations in primary non-astrocytic tumors of the central nervous system: reappraisal by yeast functional assay.Acta Neuropathol. 1998 Mar;95(3):291-6. doi: 10.1007/s004010050800. Acta Neuropathol. 1998. PMID: 9542595 Review.
Cited by
-
Germline mutations in the p53 tumour suppressor gene: scientific, clinical and ethical challenges.Br J Cancer. 1992 Sep;66(3):424-6. doi: 10.1038/bjc.1992.290. Br J Cancer. 1992. PMID: 1520579 Free PMC article. No abstract available.
-
Molecular genetics in the cancer clinic.West J Med. 1991 Nov;155(5):544-6. West J Med. 1991. PMID: 1815412 Free PMC article. No abstract available.
-
Spindle assembly checkpoint and p53 deficiencies cooperate for tumorigenesis in mice.Int J Cancer. 2009 Mar 15;124(6):1483-9. doi: 10.1002/ijc.24094. Int J Cancer. 2009. PMID: 19065665 Free PMC article.
-
Cancer risks from germline p53 mutations.J Clin Invest. 1992 Nov;90(5):1637-41. doi: 10.1172/JCI116034. J Clin Invest. 1992. PMID: 1430194 Free PMC article. Review. No abstract available.
-
Detection of multiallele polymorphisms within gene sequences by GC-clamped denaturing gradient gel electrophoresis.Am J Hum Genet. 1992 Mar;50(3):567-75. Am J Hum Genet. 1992. PMID: 1539594 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous